Skip to content

Insmed INSM Net Change in Cash

Net Change in Cash at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$336.83M+60.9%
United Therapeutics logo
United TherapeuticsUTHR
-$277.4M-237%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$236.56M+81.4%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$25.59M+418%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$153.1M-125%
Savara logo
SavaraSVRA
$5.61M+26.7%

Other financials

Income statement

See full
Revenue$306.0M+230%
Gross profit$258.5M+261%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
CapEx$3.5M-65.4%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$23.11B+17.6%
Enterprise value$23.11B+22.0%
P/S28.2×-21.1×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insmed's net change in cash?
Insmed (INSM) reported net change in cash of $71.74M in Q1 2026.
How has Insmed's net change in cash changed year-over-year?
Insmed's net change in cash increased by 147.3% year-over-year, from -$151.78M to $71.74M.
What is the long-term trend for Insmed's net change in cash?
Over 2 years (2022 to 2024), Insmed's net change in cash has grown at a -54.9% compound annual growth rate (CAGR), from $357.25M to $72.66M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.